Avoro Capital Advisors LLC - Significant Ownership

Signature - Title
/s/ Scott Epstein - Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avoro Capital Advisors LLC.

Significant Ownership of Avoro Capital Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WHWK Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 19.99% $19.7M $13.7M 11.9M +233% BEHZAD AGHAZADEH Feb 28, 2025
TRML Tourmaline Bio, Inc. Common Stock, par value $0.0001 per share 9.95% $58.9M 2.56M Avoro Capital Advisors LLC Jun 30, 2025
GPCR Structure Therapeutics Inc. Ordinary Shares, par value $0.0001 per share 9.38% $454M 16.2M Avoro Capital Advisors LLC Sep 30, 2025
VERA Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value per share 8.9% $122M 5.61M Avoro Capital Advisors LLC Dec 31, 2024
ARWR ARROWHEAD PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 8.3% $183M -$8.14M 11.5M -4.25% Avoro Capital Advisors LLC Jun 30, 2025
CNTA Centessa Pharmaceuticals plc Ordinary shares, nominal value 0.002 GBP per share 8.06% $262M 10.8M Avoro Capital Advisors LLC Sep 30, 2025
QURE uniQure N.V. Ordinary Shares, par value EUR0.05 per share 6.6% $57.2M 3.63M Avoro Capital Advisors LLC Jun 30, 2025
FOLD AMICUS THERAPEUTICS, INC. Common Stock, par value $0.01 per share 4.87% $118M -$43.1M 15M -26.7% Avoro Capital Advisors LLC Sep 30, 2025
BCRX BIOCRYST PHARMACEUTICALS INC Common Stock, $0.01 par value 4.2% $58.9M 8.7M Avoro Capital Advisors LLC Mar 31, 2025
SLNO SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share 4.1% $140M 2.05M Avoro Capital Advisors LLC Jun 30, 2025
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share 3.15% $14.3M -$15.4M 2M -51.8% Avoro Capital Advisors LLC Sep 30, 2025
BPMC Blueprint Medicines Corp Common Stock, par value $0.001 per share 0.6% $48.2M -$447M 375K -90.3% Avoro Capital Advisors LLC Jun 30, 2025
GLUE Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$27.6M 0 -100% Avoro Capital Advisors LLC Sep 30, 2025

Schedules 13D/G Reported by Avoro Capital Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.